SARS-CoV-2 antivirals and post-COVID-19 condition

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	6-8
Number of pages	3
Journal	The Lancet Infectious Diseases
Volume	25
Issue number	1
DOIs	https://doi.org/10.1016/S1473-3099(24)00436-5
State	Published - Jan 2025

Access to Document

TY - JOUR

T1 - SARS-CoV-2 antivirals and post-COVID-19 condition

AU - Al-Aly, Ziyad

PY - 2025/1

Y1 - 2025/1

UR - http://www.scopus.com/inward/record.url?scp=85204783981&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(24)00436-5

DO - 10.1016/S1473-3099(24)00436-5

M3 - Comment/debate

C2 - 39265592

AN - SCOPUS:85204783981

SN - 1473-3099

VL - 25

SP - 6

EP - 8

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 1

ER -